Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
Condition(s):MedulloblastomaLast Updated:December 11, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):MedulloblastomaLast Updated:December 11, 2023Recruiting
Condition(s):Leukemia, Promyelocytic, AcuteLast Updated:July 11, 2011Unknown status
Condition(s):Leukemia, Myeloid, AcuteLast Updated:June 27, 2023Completed
Condition(s):HPV-Associated Oropharyngeal Squamous Cell Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage; HPV-Related Squamous Cell Carcinoma; Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage; HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Pathologic StageLast Updated:July 11, 2023Recruiting
Condition(s):AmyloidosisLast Updated:March 25, 2015Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:March 7, 2024Active, not recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:February 9, 2009Completed
Condition(s):Non-Hodgkin’s LymphomaLast Updated:October 6, 2006Unknown status
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:January 7, 2009Completed
Condition(s):Hodgkin LymphomaLast Updated:October 20, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.